X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company developing novel therapies for immune system diseases. The company's lead candidate, mavorixafor, is being evaluated in clinical trials for conditions such as WHIM syndrome and chronic neutropenic disorders.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.